99 related articles for article (PubMed ID: 3013650)
1. Protective effect of a new prostacyclin analogue OP-2507 against cerebral anoxia and edema in experimental animals.
Masuda Y; Ochi Y; Ochi Y; Karasawa T; Hatano N; Kadokawa T; Okegawa T
Eur J Pharmacol; 1986 Apr; 123(3):335-44. PubMed ID: 3013650
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of prostaglandins D2, E1 and I2 against cerebral hypoxia/anoxia in mice.
Masuda Y; Ochi Y; Ochi Y; Karasawa T; Hatano N; Kadokawa T; Shimizu M
Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):282-9. PubMed ID: 3543699
[TBL] [Abstract][Full Text] [Related]
3. Effect of a prostacyclin analog OP-2507 on acute ischemic cerebral edema in cats.
Terawaki T; Takakuwa T; Iguchi S; Wakitani K; Kira H; Okegawa T; Kawasaki A; Masuda Y
Eur J Pharmacol; 1988 Jul; 152(1-2):63-70. PubMed ID: 3061830
[TBL] [Abstract][Full Text] [Related]
4. Effect of OP-2507, a stable prostacyclin analogue on cerebral ischemia induced by unilateral ligation of common carotid artery in gerbils.
Masuda Y; Yasuba M; Zushi K; Ochi Y; Kadokawa T; Okegawa T
Arch Int Pharmacodyn Ther; 1988; 294():125-36. PubMed ID: 3069063
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of flunarizine against cerebral hypoxia-anoxia in mice and rats.
Karasawa A; Kumada Y; Yamada K; Shuto K; Nakamizo N
J Pharmacobiodyn; 1982 Apr; 5(4):295-300. PubMed ID: 7120030
[TBL] [Abstract][Full Text] [Related]
6. Effect of a prostacyclin derivative (OP-41483) and a hyperosmotic agent (glycerol) on brain edema and metabolism in cerebral ischemia.
Katayama Y; Kashiwagi F; Memezawa H; Terashi A
Jpn Circ J; 1992 Dec; 56(12):1239-47. PubMed ID: 1479649
[TBL] [Abstract][Full Text] [Related]
7. A possible role of endogenously formed cerebral prostaglandins in the development of adaptive protection against cerebral hypoxia/ischemia in mice.
Masuda Y; Ochi Y; Ochi Y; Kadokawa T
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):721-7. PubMed ID: 3448451
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of R(-)-1-(benzo[b]thiophen-5-yl)- 2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588), a novel cerebral activator, against experimental cerebral anoxia.
Ono S; Kitamura K; Maekawa M; Hirata K; Ano M; Ukai W; Yamafuji T; Narita H
Jpn J Pharmacol; 1993 May; 62(1):81-6. PubMed ID: 8101887
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats.
Suzuki M; Suzuki M; Sato K; Dohi S; Sato T; Matsuura A; Hiraide A
Jpn J Pharmacol; 2001 Oct; 87(2):143-50. PubMed ID: 11700013
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of a PGI2 analogue OP-2507 on hemorrhagic shock in rats--with an evaluation of the metabolic recovery using near-infrared optical monitoring.
Tamura M
Jpn Circ J; 1992 Apr; 56(4):366-75. PubMed ID: 1315877
[TBL] [Abstract][Full Text] [Related]
11. Cerebroprotective effect of nicergoline and interference with the anti-hypoxic effect of prostacyclin.
Nikolov R; Dikova M; Nikolova M; Voronina T; Nerobkova L; Garibova T
Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):479-84. PubMed ID: 3320632
[TBL] [Abstract][Full Text] [Related]
12. Prostacyclin as a cerebroprotective agent against brain hypoxia.
Nikolov R
Biomed Biochim Acta; 1989; 48(2-3):S183-7. PubMed ID: 2658983
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of hachimi-jio-gan, an oriental herbal medicinal mixture, against cerebral anoxia.
Hirokawa S; Nose M; Amagaya S; Oyama T; Ogihara Y
J Ethnopharmacol; 1993 Dec; 40(3):201-6. PubMed ID: 8145576
[TBL] [Abstract][Full Text] [Related]
14. Study on the cerebral effects of sabeluzole.
Nikolov R; Scheller D; Nikolova M
Methods Find Exp Clin Pharmacol; 1991; 13(6):385-90. PubMed ID: 1881199
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260.
Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
Prog Brain Res; 2008; 170():519-25. PubMed ID: 18655905
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological actions of a new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia.
Yamamoto M; Shimizu M; Okamiya H
Eur J Pharmacol; 1990 Jun; 181(3):207-14. PubMed ID: 2116971
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin analogue (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury.
Chen HM; Chen MF; Shyr MH
J Surg Res; 1998 Dec; 80(2):333-8. PubMed ID: 9878334
[TBL] [Abstract][Full Text] [Related]
18. Studies on the effects of endothelin-1 (ET-1) and endothelin-3 (ET-3) in brain hypoxia and on the participation of brain prostanoids in their actions.
Nikolov R; Masuda Y; Kato H; Minato H; Semkova I; Maslarova J
Methods Find Exp Clin Pharmacol; 1993; 15(6):371-5. PubMed ID: 8231456
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 15-cis-(4-n-propylcyclohexyl)-16,17,18,19,20-pentanor-9- deoxy-6,9 alpha-nitriloprostaglandin F1 methyl ester (OP-2507), a novel anti-cerebral ischemic agent.
Iguchi S; Miyata Y; Okuyama S; Miyake H; Okegawa T
Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):1128-34. PubMed ID: 3044628
[No Abstract] [Full Text] [Related]
20. Effects of BMY-21502 on anoxia in mice.
Amano M; Goto A; Takahashi N; Hasegawa T; Nabeshima T
Jpn J Pharmacol; 1993 Mar; 61(3):157-63. PubMed ID: 8483292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
